A detailed history of Advisor Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisor Partners LLC holds 32,766 shares of NVO stock, worth $2.81 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
32,766
Previous 30,905 6.02%
Holding current value
$2.81 Million
Previous $3.43 Million 6.38%
% of portfolio
0.26%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $192,129 - $226,688
1,861 Added 6.02%
32,766 $3.65 Million
Q1 2022

Apr 27, 2022

SELL
$93.1 - $112.54 $179,031 - $216,414
-1,923 Reduced 5.86%
30,905 $3.43 Million
Q4 2021

Feb 04, 2022

BUY
$95.88 - $117.08 $101,249 - $123,636
1,056 Added 3.32%
32,828 $3.68 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $61,626 - $77,832
-730 Reduced 2.25%
31,772 $3.05 Million
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $32,950 - $41,278
487 Added 1.52%
32,502 $2.72 Million
Q1 2021

Jun 01, 2021

BUY
$67.06 - $75.82 $211,104 - $238,681
3,148 Added 10.91%
32,015 $2.16 Million
Q4 2020

Feb 17, 2021

BUY
$63.89 - $73.8 $67,020 - $77,416
1,049 Added 3.77%
28,867 $2.02 Million
Q3 2020

Nov 19, 2020

BUY
$63.69 - $70.22 $59,168 - $65,234
929 Added 3.45%
27,818 $1.93 Million
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $316,408 - $367,215
5,405 Added 25.16%
26,889 $1.76 Million
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $231,176 - $302,781
4,674 Added 27.8%
21,484 $1.29 Million
Q4 2019

Jan 24, 2020

BUY
$49.86 - $58.26 $43,826 - $51,210
879 Added 5.52%
16,810 $1.05 Million
Q3 2019

Oct 16, 2019

BUY
$47.54 - $53.43 $54,433 - $61,177
1,145 Added 7.74%
15,931 $824,000
Q2 2019

Jul 26, 2019

BUY
$46.79 - $52.47 $35,607 - $39,929
761 Added 5.43%
14,786 $755,000
Q1 2019

Apr 23, 2019

BUY
$46.36 - $52.63 $64,486 - $73,208
1,391 Added 11.01%
14,025 $734,000
Q4 2018

Jan 29, 2019

BUY
$41.54 - $47.25 $14,040 - $15,970
338 Added 2.75%
12,634 $582,000
Q3 2018

Nov 06, 2018

BUY
$46.76 - $51.24 $89,358 - $97,919
1,911 Added 18.4%
12,296 $580,000
Q2 2018

Jul 25, 2018

SELL
$44.29 - $50.42 $92,433 - $105,226
-2,087 Reduced 16.73%
10,385 $479,000
Q1 2018

May 03, 2018

BUY
$48.49 - $58.14 $90,773 - $108,838
1,872 Added 17.66%
12,472 $614,000
Q4 2017

Jan 26, 2018

BUY
$47.53 - $53.73 $223,058 - $252,154
4,693 Added 79.45%
10,600 $613,000
Q3 2017

Nov 03, 2017

BUY
$41.15 - $49.22 $243,073 - $290,742
5,907
5,907 $284,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $193B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Advisor Partners LLC Portfolio

Follow Advisor Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.